Literature DB >> 1424668

Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model.

D C Gritz1, S Kwitko, M D Trousdale, V H Gonzalez, P J McDonnell.   

Abstract

Recurrence of Pseudomonas keratitis during treatment with corticosteroids has been reported previously in humans. Rabbits with keratitis due to Pseudomonas aeruginosa or Streptococcus pneumoniae were treated with antibiotics and either vehicle, methylprednisolone acetate, flurbiprofen, or nordihydroguaiaretic acid (NDGA). Cultures performed after 7 days were negative, and antibiotics were discontinued. Two weeks later, Pseudomonas keratitis recurred in 6 of 7 (85.7%) steroid-treated rabbits, 1 of 8 (12.5%) flurbiprofen-treated rabbits, 1 of 8 (12.5%) NDGA-treated rabbits, and none of 8 vehicle-treated rabbits. None of the 31 rabbits infected with Streptococcus pneumoniae experienced recurrence. These data confirm the clinical observation that Pseudomonas keratitis may recur if antibiotic therapy is discontinued and corticosteroids are administered; the risk of recurrence appears to be much less with nonsteroidal antiinflammatory agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424668     DOI: 10.1097/00003226-199209000-00008

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  11 in total

1.  Topical Corticosteroids in the Management of Bacterial Keratitis.

Authors:  Sonal S Tuli
Journal:  Curr Ophthalmol Rep       Date:  2013-12

2.  Matrix Metalloproteinase-13 as a Target for Suppressing Corneal Ulceration Caused by Pseudomonas aeruginosa Infection.

Authors:  Nan Gao; Ashok Kumar; Fu-Shin X Yu
Journal:  J Infect Dis       Date:  2015-01-13       Impact factor: 5.226

Review 3.  Update on the Management of Infectious Keratitis.

Authors:  Ariana Austin; Tom Lietman; Jennifer Rose-Nussbaumer
Journal:  Ophthalmology       Date:  2017-09-21       Impact factor: 12.079

4.  Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.

Authors:  Aileen Sy; Muthiah Srinivasan; Jeena Mascarenhas; Prajna Lalitha; Revathi Rajaraman; Meenakshi Ravindran; Catherine E Oldenburg; Kathryn J Ray; David Glidden; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

5.  Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital.

Authors:  Ali Al-Shehri; Sabah Jastaneiah; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2008-04-03       Impact factor: 2.031

Review 6.  Pharmacokinetic considerations in the treatment of bacterial keratitis.

Authors:  M C Callegan; R J O'Callaghan; J M Hill
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

Review 7.  Role of steroids in the treatment of bacterial keratitis.

Authors:  Sotiria Palioura; Christopher R Henry; Guillermo Amescua; Eduardo C Alfonso
Journal:  Clin Ophthalmol       Date:  2016-01-27

8.  Clinical analysis of microbiologically proven fungal keratitis according to prior topical steroid use: a retrospective study in South Korea.

Authors:  Chan-Ho Cho; Sang-Bumm Lee
Journal:  BMC Ophthalmol       Date:  2019-10-16       Impact factor: 2.209

9.  Suppression of lipopolysaccharide-induced corneal opacity by hepatocyte growth factor.

Authors:  Elsayed Elbasiony; WonKyung Cho; Sharad K Mittal; Sunil K Chauhan
Journal:  Sci Rep       Date:  2022-01-11       Impact factor: 4.379

10.  Double-masked, sham and placebo-controlled trial of corneal cross-linking and topical difluprednate in the treatment of bacterial keratitis: Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II) study protocol.

Authors:  Naveen Radhakrishnan; Venkatesh N Prajna; Lalitha S Prajna; Anitha Venugopal; Shivanandha Narayana; Revathi Rajaraman; Guillermo Amescua; Travis C Porco; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  BMJ Open Ophthalmol       Date:  2021-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.